Mayfield, UK | March 15th 2020 With major events cancelling across Europe and the US over the past few days, we know that many of our customers are asking questions about our forthcoming training courses and conferences. With the increasing number of Covid-19 cases and travel restrictions / bans, we have a duty of care

Dr John Studley (JS) spoke to Heather Johnson (HJ) from Merck ahead of Heather’s presentation at our Organic Process Research & Development Conference. JS – The Science paper describing the design of a biocatalytic cascade for the manufacture of Islatravir (Science 2019, 366, 1255,) published by Merck and Codexis at the end of last year, represents

Dr John Studley (JS) from Scientific Update spoke to Dr David Barnes (DB) from Abbvie in the US  ahead of our ‘Organic Process Research and Development’ Conference which is taking place in Clearwater, Florida on 9-11 March. We are looking forward to your presentation ‘Discovery of Novel Catalytic Technologies in the Development of Complex Clinical

We were absolutely delighted to present the awards to our 11 Winners of our ‘Young Chemist Award’ at our ‘6th Winter Process Chemistry Conference’ in Birmingham today. They have all presented their work at the conference and it has been fantastic to hear from them all. Thanks to our judges – Ian Lennon at #chiralquest,

Dr John Studley, Science Director at Scientific Update and Dr William Goundry from Astra Zeneca got together ahead of our forthcoming Organic Process R&D Conference in Lisbon, Portugal on 23-25 September. Q: Dr John Studley (JS) We are looking forward to your presentation ‘The Good, the Bad and the Ugly! Successes and Failures from the

The keynote speaker at our recent ‘Polymorphism and Crystallisation’ Conference in Boston was Dr Susan M. Reutzel-Edens from Eli Lilly, whose name will very familiar to anyone working in the solid form / crystallisation and she gave what one delegate described as “the best talk I have ever heard”. Now I can’t entirely agree with

Dr John Studley, Scientific Director at Scientific Update recently spoke to Professor Ben List, Max Planck Institute, Germany ahead of his Key Note lecture at the 2019 Catalysis in the Pharmaceutical and Fine Chemical Industry Conference, in Lucerne, Switzerland. Ben will talk about “how we have designed and developed a novel class of extremely reactive

We had a fantastic turn out for our #OPRDUS18 Conference in Clearwater, Florida last month. It was great to see our speakers, exhibitors and attendees and the feedback we received was excellent. Thank you for coming along! Our Technical Director Dr Will Watson opened the conference and we invited Dr Paul Murray and Dr André de

The Scale Up of Chemical Processes Conference, June 21st – 23rd 2017 took place in Rochester, NY. For a review of the event by sponsors Kodak Speciality Chemicals – Click HERE

Meanwhile in another presentation from the 4th Winter Process Conference this time from Alexandra Parker of AstraZeneca discussed the development of the manufacturing route to make Lesinurad (Zurampic) a selective uric acid reabsorption inhibitor approved for treatment of hyperuricemia associated with gout in combination with a xanthine oxidase inhibitor (XOI) in patients unable to achieve